|
RCHY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.225000E-04 |
| Normal-vs-Stage3 |
8.99349994476495E-09 |
| Normal-vs-Stage4 |
2.91559999476831E-08 |
| Stage1-vs-Stage2 |
1.507200E-01 |
| Stage1-vs-Stage3 |
4.582800E-01 |
| Stage1-vs-Stage4 |
9.384800E-01 |
| Stage2-vs-Stage3 |
7.503800E-02 |
| Stage2-vs-Stage4 |
3.195200E-01 |
| Stage3-vs-Stage4 |
5.718600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.37060000413325E-08 |
| Normal-vs-Asian |
5.167800E-02 |
| Caucasian-vs-AfricanAmerican |
1.033580E-01 |
| Caucasian-vs-Asian |
8.304800E-01 |
| AfricanAmerican-vs-Asian |
7.106600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
9.76890013326681E-10 |
| Male-vs-Female |
7.272000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.82280000380086E-08 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
2.49145148956131E-12 |
| Normal-vs-Extreme_Obese |
1.648440E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.257400E-01 |
| Normal_Weight-vs-Obese |
8.286600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.000000E+00 |
| Extreme_Weight-vs-Obese |
1.054410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.219600E-01 |
| Obese-vs-Extreme_Obese |
8.873000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.08200004511616E-10 |
| Normal-vs-Age(41-60Yrs) |
1.626032641866E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
5.53009999999521E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.775000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.745000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.823400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.308800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.105800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.438800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.03000052931179E-10 |
| Normal-VS-KIRP CIMP |
1.829870E-04 |
| Normal-VS-Unclassified PRCC |
2.61329846651392E-11 |
| Type1 PRCC-VS-Type2 PRCC |
3.182000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.023600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.270800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.948600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.055400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.892600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65345515057425E-12 |
| Normal-vs-N1 |
6.11140000050803E-07 |
| Normal-vs-N2 |
1.34769995163708E-09 |
| N0-vs-N1 |
6.950400E-01 |
| N0-vs-N2 |
1.073360E-01 |
| N1-vs-N2 |
1.167560E-01 |
|
|
